JRSS — JRSIS HEALTH CARE Cashflow Statement
0.000.00%
- $1.10m
- $2.40m
- $3.46m
Annual cashflow statement for JRSIS HEALTH CARE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.27 | 3.83 | 3.19 | -33.7 | -0.095 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.55 | 0.955 | 1.4 | 36.8 | -0.038 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.18 | 1.8 | -0.406 | -0.043 | 0.591 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 11.8 | 10.6 | 8.23 | 3.07 | 0.517 |
| Capital Expenditures | -4.71 | -8.27 | -2.31 | -0.045 | -0.001 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.751 | — | -3.19 | -2.78 | 0.02 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.96 | -8.27 | -5.5 | -2.83 | 0.019 |
| Financing Cash Flow Items | -8.76 | -6.12 | -5.43 | -0.807 | -0.014 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.11 | -3.43 | -2.8 | -0.738 | -0.568 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.71 | -1.13 | 0.011 | -0.797 | -0.041 |